Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Use in Electroconvulsive Therapy: Clinical, Cognitives and Neurotrophic Outcomes

NCT02012335 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.

NCT NCT02012335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02012335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Use in Electroconvulsive Therapy: Clinical, Cognitives and Neurotrophic Outcomes
Lead sponsor
Hospital de Clinicas de Porto Alegre
Phase
Not applicable
Overall status
Withdrawn
Start date
January 31, 2014
Completion date
January 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression